Company intelligence / Profile preview

Beehive Capital

London, London, United Kingdom

Ownership: Private
Development stage: Other

Overview

Beehive Capital is a London-based boutique investment bank and private equity firm that specializes in the biopharmaceutical and healthcare sectors. Founded in 2002 by industry veteran Stephen Mayo, the firm is notable for its role in founding and managing major life science investment vehicles, most notably Celtic Pharma Holdings. Beehive Capital operates by identifying undervalued clinical-stage drug candidates and providing the strategic capital and management expertise necessary to advance them through late-stage development and commercialization. Through its association with Celtic Pharma and Pro Bono Bio, the firm has been instrumental in the development of various therapeutic products, including the osteoarthritis treatment Flexiseq.

Industry: Investors

Partnerships

RusnanoCeltic Pharma

Beyond the preview

Go deeper on Beehive Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Beehive Capital.

Explore the full profile